Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/20/2012US8138207 Antidiabetic agents, carbohydrate and lipid metabolic disorders; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-y]-benzamide trifluoroacetic acid salt for example; use in combination with other drugs
03/20/2012US8138206 Piperidine derivative
03/20/2012US8138205 Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
03/20/2012US8138204 Emesis, dyspepsia, gastroparesis, constipation, gastroesophageal reflux, or post-operative ileus; cisapride analogs; side effect reduction of adverse events; (R)-quinuclidin-3-yl 6-((3S,4R)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate or salts
03/20/2012US8138202 Stable SNS-595 compositions and methods of preparation
03/20/2012US8138201 Treatment of progressive neurodegenerative disease with ibudilast
03/20/2012US8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells
03/20/2012US8138199 Use of bi-aryl meta-pyrimidine inhibitors of kinases
03/20/2012US8138198 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138197 Spirochromanon derivatives
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138194 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
03/20/2012US8138193 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
03/20/2012US8138192 Injectable meclizine formulations and methods
03/20/2012US8138191 Inhibitor compounds and cancer treatment methods
03/20/2012US8138190 Diaza heterocyclic amide compounds and their uses
03/20/2012US8138189 Substituted benzene compounds as modulators of the glucocorticoid receptor
03/20/2012US8138188 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
03/20/2012US8138187 Substituted heteroaryl derivatives
03/20/2012US8138186 Pyrazole derivatives as sigma receptors antagonists
03/20/2012US8138185 Urea glucokinase activators
03/20/2012US8138184 Isoxazole derivatives and pharmaceutical compositions comprising the same
03/20/2012US8138183 Morpholino pyrimidine derivatives used in diseases linked to mTOR kinase and/or PI3K
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012US8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
03/20/2012US8138180 Exo-selective synthesis of himbacine analogs
03/20/2012US8138179 Spiro-imidazo compounds
03/20/2012US8138178 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/20/2012US8138177 Benzimidazolone derivatives as CB2 receptor ligands
03/20/2012US8138176 Imidazo compounds
03/20/2012US8138175 Heterocyclyl compounds
03/20/2012US8138174 Such as N-{1-[7-(2-amino-ethoxyimino)-7-[4-(trifluoromethyl)phenyl]heptylamino]-1-[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-methylidene)-4-chloro-benzenesulfonamide; pain. psychosis, anxiety, depression, attention deficits, cognitive disorders, obesity; neurodegenerative disorders
03/20/2012US8138173 Pyrazolo[3,4-C]quinolines, pyrazolo[3,4-C]naphthyridines, analogs thereof, and methods
03/20/2012US8138172 8-oxoadenine derivatives acting as modulators of TLR7
03/20/2012US8138171 Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors
03/20/2012US8138170 Inhibiting transplant rejection and inflammatory cell accumulation; wound healing agents, antiallergens
03/20/2012US8138169 Combination therapy for bipolar disorder
03/20/2012US8138168 Renin inhibitors
03/20/2012US8138166 Method to induce fatty liver in animal
03/20/2012US8138165 Chromones and chromone derivatives and uses thereof
03/20/2012US8138164 HCV NS3 protease inhibitors
03/20/2012US8138163 Aldehyde conjugated flavonoid preparations
03/20/2012US8138162 Natural sweetener
03/20/2012US8138159 Composition for inhibiting function of human Flt3
03/20/2012US8138158 Compositions and methods for therapy for diseases characterized by defective chloride transport
03/20/2012US8138157 Antibiotic formulation and method of treatment
03/20/2012US8138156 Ophthalmic compositions containing diglycine
03/20/2012US8138144 Antimicrobial cationic peptides and formulations thereof
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8137994 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
03/20/2012US8137993 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
03/20/2012US8137992 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
03/20/2012US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
03/20/2012US8137918 Sperm-specific cation channel, CatSper4, and uses therefor
03/20/2012US8137915 Genes involved in intestinal inflammatory diseases and use thereof
03/20/2012US8137711 Methods of treating neuropathy
03/20/2012US8137696 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
03/20/2012US8137694 Immediate release and sustained release ibuprofen dosing regimen
03/20/2012US8137688 Hydroxyphenyl cross-linked macromolecular network and applications thereof
03/20/2012US8137685 Reaction product of hyaluronic acid and a phosphatidyl ethanolamine; biocompatibility and bio-safety; formed or molded to shape used to treat a knee joint; prevent accretion of a tissue after an operation; keep skin wet
03/20/2012US8137684 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
03/20/2012US8137683 Process for the preparation of dispersions
03/20/2012US8137664 Method and kit for repairing a defect in bone
03/20/2012US8137659 Metal oxide composition
03/20/2012CA2683738C Indanone derivatives that inhibit prolyl hydroxylase
03/20/2012CA2680246C Piperazinyl-propyl-pyrazole derivatives as dopamine d4 receptor antagonists, and pharmaceutical compositions containing the same
03/20/2012CA2676907C Tricyclic compounds and their use as glucocorticoid receptor modulators
03/20/2012CA2674078C Topical administration of danazol
03/20/2012CA2672656C Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
03/20/2012CA2656507C Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
03/20/2012CA2636324C Cycloalkylamines as monoamine reuptake inhibitors
03/20/2012CA2628131C Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/20/2012CA2627531C Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer
03/20/2012CA2579840C Carboxamide spirolactam cgrp receptor antagonists
03/20/2012CA2577497C 15.beta.-substituted steroids having selective estrogenic activity
03/20/2012CA2563659C Method of treating dry eye disorders and uveitis
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2540196C Pyridine derivatives and use thereof as urotensin ii antagonists
03/20/2012CA2529749C Omega-3 fatty acids for the treatment of canine osteoarthritis
03/20/2012CA2526026C Furazanobenzimidazoles
03/20/2012CA2524900C 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
03/20/2012CA2520109C Use of an ibat inhibitor for the treatment or prophylaxis of constipation
03/20/2012CA2518115C Nucleotide phosphoramidates as anticancer agents
03/20/2012CA2515293C Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
03/20/2012CA2513583C Modified retinoid compounds and their uses
03/20/2012CA2509139C Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
03/20/2012CA2507765C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
03/20/2012CA2505029C Isoindoline derivatives
03/20/2012CA2498634C A process for the preparation of drospirenone
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2491989C Compounds with antiparasitic activity and medicines containing same
03/20/2012CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
03/20/2012CA2474688C Improved process for obtaining betulinic acid
03/20/2012CA2472711C 2-acylaminothiazole derivative or salt thereof
03/20/2012CA2462227C Adhesive antineoplastic compositions
03/20/2012CA2456721C Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders
03/20/2012CA2453510C Treatment of fatigue and cognitive side effects associated with cancer, cancer treatments and menopause with d-threo-methyphenidate
03/20/2012CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/20/2012CA2424359C Implants with a phosphazene-containing coating
03/20/2012CA2406206C Improvements in or relating to formulations for use in inhaler devices
1 ... 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 ... 7860